GMM Pfaudler (505255) Q4 03/04 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 03/04 earnings summary
2 Nov, 2026Executive summary
FY04 sales and other income rose to Rs 638.5m from Rs 536.1m; PBT more than doubled to Rs 73.8m and net profit reached Rs 62.1m.
Improved market share and cost control supported results; year-end backlog reached Rs 356.6m, up from Rs 246.5m at end-May 2003.
Financial highlights
Income from operations was Rs 589.7m versus Rs 521.8m; other income increased to Rs 48.8m from Rs 14.3m.
PBT was Rs 73.8m versus Rs 34.5m; reported profit after tax was Rs 62.1m versus Rs 23.7m.
Basic and diluted EPS rose to Rs 21.25 from Rs 8.12.
Other income included Rs 14.9m net gain on fixed-asset sales and Rs 5.2m gain on current-investment sales.
Outlook and guidance
Backlog at end-May 2004 was Rs 356.6m versus Rs 246.5m a year earlier, reflecting marketing, sales and product-development initiatives.
Pharma Glass PPG gained adoption among pharmaceutical customers; Economix glass-lined agitators with Cryolock technology were gaining traction in fine chemicals and pharmaceuticals.
Thermal Control Units and other products in development were expected to contribute to future business.
Agri-industry was identified as a fast-growing customer sector, with improved product demand expected in FY05.
Latest events from GMM Pfaudler
- Record orders and backlog support growth as European losses weigh on reported margins.505255
Q2 26/27 - Sales and profits declined as exports, reglassing and new products became growth priorities.505255
Q4 96/97 - Recession drove sharp FY98 declines as exports and cost cuts became the recovery levers.505255
Q4 97/98 - Higher sales and record orders were offset by lower profits and depressed pricing.505255
Q4 98/99 - Revenue grew, profit weakened, while Q1 sales and backlog rebounded.505255
Q4 99/00 - Export growth lifted sales, but recession and margin pressure cut pre-tax profit.505255
Q4 00/01 - Sales and profit fell, but backlog grew as product and technology investments advanced.505255
Q4 01/02 - Profit more than tripled as backlog grew, despite pricing, power and investment risks.505255
Q4 02/03 - FY05 profits surged, backlog grew, but pricing, power and Nile litigation remained risks.505255
Q4 04/05